Cell Therapy with Human Renal Cell Cultures Containing Erythropoietin-Positive Cells Improves Chronic Kidney Injury

New therapeutic strategies for chronic kidney disease (CKD) are necessary to offset the rising incidence of CKD and donor shortage. Erythropoietin (EPO), a cytokine produced by fibroblast-like cells in the kidney, has recently emerged as a renoprotective factor with anti-inflammatory, antioxidant pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yamaleyeva, Liliya M., Guimaraes-Souza, Nadia K., Krane, Louis S., Agcaoili, Sigrid, Gyabaah, Kenneth, Atala, Anthony, Aboushwareb, Tamer, Yoo, James J.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2012
Sujets:
Original Articles and Reviews
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659702/
https://ncbi.nlm.nih.gov/pubmed/23197816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2011-0048
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires